These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33894619)

  • 1. The subunit vaccine H65 + CAF01 increased the BCG- protection against Mycobacterium bovis infection in a mouse model of bovine tuberculosis.
    Blanco FC; García EA; Aagaard C; Bigi F
    Res Vet Sci; 2021 May; 136():595-597. PubMed ID: 33894619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H65 fusion protein fails to improve the protection of a rationally attenuated live vaccine candidate against bovine tuberculosis in a mouse model of tuberculosis.
    García EA; Blanco FC; Bigi F
    Int J Mycobacteriol; 2021; 10(4):411-413. PubMed ID: 34916460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.
    Skinner MA; Ramsay AJ; Buchan GS; Keen DL; Ranasinghe C; Slobbe L; Collins DM; de Lisle GW; Buddle BM
    Immunology; 2003 Apr; 108(4):548-55. PubMed ID: 12667217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced protection against bovine tuberculosis after coadministration of Mycobacterium bovis BCG with a Mycobacterial protein vaccine-adjuvant combination but not after coadministration of adjuvant alone.
    Wedlock DN; Denis M; Painter GF; Ainge GD; Vordermeier HM; Hewinson RG; Buddle BM
    Clin Vaccine Immunol; 2008 May; 15(5):765-72. PubMed ID: 18337375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterologous Boost Following
    Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X
    Front Immunol; 2018; 9():2439. PubMed ID: 30425711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Mycobacterium bovis intranasal challenge model in mice.
    Logan KE; Gavier-Widen D; Hewinson RG; Hogarth PJ
    Tuberculosis (Edinb); 2008 Sep; 88(5):437-43. PubMed ID: 18590980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination of cattle with a CpG oligodeoxynucleotide-formulated mycobacterial protein vaccine and Mycobacterium bovis BCG induces levels of protection against bovine tuberculosis superior to those induced by vaccination with BCG alone.
    Wedlock DN; Denis M; Skinner MA; Koach J; de Lisle GW; Vordermeier HM; Hewinson RG; van Drunen Littel-van den Hurk S; Babiuk LA; Hecker R; Buddle BM
    Infect Immun; 2005 Jun; 73(6):3540-6. PubMed ID: 15908383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against bovine tuberculosis induced by oral vaccination of cattle with Mycobacterium bovis BCG is not enhanced by co-administration of mycobacterial protein vaccines.
    Wedlock DN; Aldwell FE; Vordermeier HM; Hewinson RG; Buddle BM
    Vet Immunol Immunopathol; 2011 Dec; 144(3-4):220-7. PubMed ID: 22005585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live attenuated Mycobacterium bovis strains combined with the encapsulated H65 antigen as a vaccine strategy against bovine tuberculosis in a mouse model.
    Onnainty R; Marini MR; Gravisaco MJ; García EA; Aagaard C; Canal A; Granero G; Bigi F; Blanco FC
    Vet Microbiol; 2024 Apr; 291():110007. PubMed ID: 38335676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis.
    Skinner MA; Buddle BM; Wedlock DN; Keen D; de Lisle GW; Tascon RE; Ferraz JC; Lowrie DB; Cockle PJ; Vordermeier HM; Hewinson RG
    Infect Immun; 2003 Sep; 71(9):4901-7. PubMed ID: 12933831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines designed to protect against Mycobacterium tuberculosis infection may aid the identification of novel vaccine constructs and diagnostic antigens for bovine tuberculosis.
    Pirson C; Vipond J; Hall Y; Williams A; Vordermeier HM
    Vet Microbiol; 2011 Mar; 148(2-4):232-7. PubMed ID: 20880640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on vaccination of cattle and wildlife populations against tuberculosis.
    Buddle BM; Wedlock DN; Denis M; Vordermeier HM; Hewinson RG
    Vet Microbiol; 2011 Jul; 151(1-2):14-22. PubMed ID: 21420804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of vaccination trials for control of tuberculosis in cattle, wildlife and humans.
    Buddle BM; Parlane NA; Wedlock DN; Heiser A
    Transbound Emerg Dis; 2013 Nov; 60 Suppl 1():136-46. PubMed ID: 24171859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of Mycobacterium tuberculosis antigens in Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle.
    Mustafa AS; Skeiky YA; Al-Attiyah R; Alderson MR; Hewinson RG; Vordermeier HM
    Infect Immun; 2006 Aug; 74(8):4566-72. PubMed ID: 16861643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An ESAT-6:CFP10 DNA vaccine administered in conjunction with Mycobacterium bovis BCG confers protection to cattle challenged with virulent M. bovis.
    Maue AC; Waters WR; Palmer MV; Nonnecke BJ; Minion FC; Brown WC; Norimine J; Foote MR; Scherer CF; Estes DM
    Vaccine; 2007 Jun; 25(24):4735-46. PubMed ID: 17499400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrapulmonary (i.pulmon.) Pull Immunization With the Tuberculosis Subunit Vaccine Candidate H56/CAF01 After Intramuscular (i.m.) Priming Elicits a Distinct Innate Myeloid Response and Activation of Antigen-Presenting Cells Than i.m. or i.pulmon. Prime Immunization Alone.
    Thakur A; Pinto FE; Hansen HS; Andersen P; Christensen D; Janfelt C; Foged C
    Front Immunol; 2020; 11():803. PubMed ID: 32457748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of IFN-gamma producing cells correlates with adjuvant enhancement of bacille Calmette-Guèrin induced protection against Mycobacterium bovis.
    Logan KE; Chambers MA; Hewinson RG; Hogarth PJ
    Vaccine; 2005 Dec; 23(48-49):5526-32. PubMed ID: 16105710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and Protective Efficacy of a Fusion Protein Tuberculosis Vaccine Combining Five Esx Family Proteins.
    Xiang ZH; Sun RF; Lin C; Chen FZ; Mai JT; Liu YX; Xu ZY; Zhang L; Liu J
    Front Cell Infect Microbiol; 2017; 7():226. PubMed ID: 28620588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of different adjuvants on the immune responses of cattle vaccinated with Mycobacterium tuberculosis culture filtrate proteins.
    Wedlock DN; Keen DL; McCarthy AR; Andersen P; Buddle BM
    Vet Immunol Immunopathol; 2002 May; 86(1-2):79-88. PubMed ID: 11943331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation between Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle by using recombinant mycobacterial antigens.
    Buddle BM; Parlane NA; Keen DL; Aldwell FE; Pollock JM; Lightbody K; Andersen P
    Clin Diagn Lab Immunol; 1999 Jan; 6(1):1-5. PubMed ID: 9874655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.